Autolus Therapeutics plc American Depositary Share is a biopharmaceutical company primarily focused on the development and commercialization of innovative T cell immunotherapy treatments for cancer patients. With a robust pipeline and cutting-edge technology, Autolus Therapeutics is poised to make a significant impact in the field of oncology.
